| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M37-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61D7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-80 |
| filingDate |
2000-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e9a781613a151156e1f457f421548ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fd38ce1e50ad9a2281483fb8b13f907
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17c5a353ac2d2178e5bbba8aa0dd3115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d212e7cca58285e7abe39b439217506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d7bc997b88679a15a6f819196021df7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4549ef972d3d2d54e0b979481c0506e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efef49489a3c4c63615df4b6027939de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc7815d4eeb46853553283c986f08596
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6191256e6023f932316328818a27245f |
| publicationDate |
2002-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2002032401-A1 |
| titleOfInvention |
Osmotic beneficial agent delivery system |
| abstract |
An osmotic beneficial agent delivery system includes an implantable osmotic delivery device and a catheter for delivery of the beneficial agent from the delivery device to a delivery location. The beneficial agent delivery system includes a catheter and a docking station which are implanted in the patient with a distal end of the catheter positioned at a delivery site. The catheter and docking station are left in place while an implant containing the beneficial agent is removably connected to the catheter at the docking station and can be replaced as needed. The docking station provides a connection between a catheter and the implant allowing the implant to be replaced periodically while the catheter and the docking station remain in place. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010317913-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9056204-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9981129-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005234431-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10516953-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011034755-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11071869-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9635472-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010008630-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11577078-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8771166-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009048583-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8657734-B2 |
| priorityDate |
1999-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |